Zentiva ended 2019 on the 13th place in the same ranking.
Its market share therefore increased from 2.3% in 2019 to 4.6% in 2020, doubling in a year. It also climbed in the ranking by sales volumes, from second to first place.
Demand for drugs to help people fight the new virus, as paracetamol was included in the treatment protocol for less serious symptoms, Zentiva climbed ahead international giants. Number one by sales is French-held Sanofi, followed by Switzerland’s Novartis, which has a plant in Romania – Sandoz in Targu-Mures.
Sandoz (Novartis), Zentiva and Terapia (Sun Pharma) are the only top ten pharmaceutical companies by sales in Romania which have plants in this country. The three are also among the largest pharmaceutical producers, with a market share of more than 13% in Romania.
Zentiva group held by private equity firm Advent International bought the Central and Eastern European operations of Alvogen in 2019. The deal added a plant to Zentiva, Labormed in Bucharest.
Zentiva Romania ended 2020 with RON602 million sales, an increase of more than 7% year-on-year and RON61.3 million profit, 40% higher than in 2019, according to its preliminary financial report.
(English version by Loredana Fratila-Cristescu)